MAYWOOD, Ill. -- As the population ages, neurologists will be challenged by a growing population of patients with stroke, dementia, Parkinson's disease and epilepsy.
The expected increase in these and other age-related neurologic disorders is among the trends that Loyola University Health System neurologists Dr. José Biller and Dr. Michael J. Schneck describe in a January, 2011, article in the journal Frontiers in Neurology.
In the past, treatment options were limited for patients with neurological disorders. "Colloquially, the neurologist would 'diagnose and adios,'" Biller and Schneck wrote in the article, titled "The Future of Neurology."
But now neurologists are seeing an "explosive growth in potential medical therapies," including new drugs, stem cell technology, gene therapies and treatments that suppress the immune system, Biller and Schneck wrote.
New tests and treatments have led to an "explosion of opportunity, with both increased demand for neurologists and an increased number of people interested in the field."
Traditionally, neurologists relied on their clinical skills and experience to diagnose neurological disorders. But now neurologists are increasingly relying on new diagnostic tests.
Diagnostic testing "has superseded the neurologic history and physical examination, which were never as accurate as we cared to admit," Biller and Schneck wrote. "We respectfully suggest that the future of neurology will be critically dependent on harmonizing the tensions between clinical skills and an over-reliance on testing paradigms."
Biller is editor-in-chief of Frontiers in Neurology, a new, peer-reviewed and open-access scholarly journal. All articles are permanently available online, free of charge.
Biller is chairman of the Department of Neurology and Schneck is a professor in the Departments of Neurology and Neurological Surgery of Loyola University Chicago Stritch School of Medicine. Schneck also is vice chair of Research and Faculty Development in the Department of Neurology.